Asta Co Ltd is a Korea-based company mainly engaged in the manufacture and sale of mass spectrometry equipment. The Company is mainly engaged in the manufacture and sale of matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF) based mass spectrometers and related consumables, which are mainly applied in display, secondary battery, and semiconductor industries.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

End-of-day quote Korea S.E. Other stock markets 2026-03-24			5-day change	1st Jan Change
6,070.00 ^KRW	-2.57%		-.--%	-26.60%

03-23	Asta wins 441 million won order	RE
02-24	ASTA Corporation announced that it expects to receive KRW 6 billion in funding from Samsung Securities Co.,Ltd., BOOKOOK Securities Co., Ltd., JB Woori Capital Co., Ltd.	CI

Market Cap	80.69B 124,414B 71.04B 65.53B 61.29B 115B 7,606B 117B 787B 305B 3,752B 303B 296B 13,054B	P/E 2021	-15.4x	P/E 2022	-17.8x
Enterprise Value	77.96B 120,210B 68.64B 63.31B 59.21B 111B 7,349B 113B 761B 295B 3,625B 293B 286B 12,613B	EV / Sales 2021	21.1x	EV / Sales 2022	14.4x
Free-Float	53.99%	Yield 2021 *	-	Yield 2022	-

03-23	Asta wins 441 million won order	RE
02-24	ASTA Corporation announced that it expects to receive KRW 6 billion in funding from Samsung Securities Co.,Ltd., BOOKOOK Securities Co., Ltd., JB Woori Capital Co., Ltd.	CI
02-24	ASTA Corporation announced that it has received KRW 10.464 billion in funding from SD Biosensor, Inc.	CI
02-09	ASTA Corporation announced that it expects to receive KRW 10.464 billion in funding from SD Biosensor, Inc.	CI
02-09	SD Biosensor, Inc. entered into a Share Purchase Agreement to acquire 27.19% stake in ASTA Corporation from Cho Eung-jun and Kim Yang-sun for KRW 32.8 billion.	CI
12-28	ASTA Corporation announced that it has received KRW 2.000664 billion in funding from Robots And Design Co., Ltd.	CI
12-18	ASTA Corporation announced that it expects to receive KRW 2.000664 billion in funding from Robots And Design Co., Ltd.	CI
25-09-29	ASTA Corporation announced that it has received KRW 2.0000304 billion in funding	CI
25-08-11	ASTA Corporation announced that it expects to receive KRW 2.0000304 billion in funding	CI
25-06-29	ASTA Corporation announced that it has received KRW 2.700036 billion in funding from KB Securities Co., Ltd.	CI
25-06-19	ASTA Corporation announced that it expects to receive KRW 2.700036 billion in funding	CI
25-03-09	ASTA Corporation announced that it has received KRW 3 billion in funding	CI
25-03-05	ASTA Corporation announced that it expects to receive KRW 3 billion in funding	CI

1 day	-2.57%
6 months	-18.52%
Current year	-26.60%

ASTA Corporation Stock

Stocks

A246720

KR7246720007

Medical Equipment, Supplies & Distribution

Valuation: ASTA Corporation

Chart: ASTA Corporation

Latest news : ASTA Corporation

Quotes and Performance

Course Extremes

Managers and Directors: ASTA Corporation

Other Medical Equipment, Supplies & Distribution

Financials

Company Profile

Current year	5,900	11,080
1 year	4,440	11,080
3 years	3,810	12,400
5 years	3,060	13,050
10 years	2,780	29,500

Manager	Title	Age	Since
Eung-Jun Cho CEO	Chief Executive Officer	72	2005-12-31
Jong-Wan Park DFI	Director of Finance/CFO	56	2018-10-31
Yang-Sun Kim CEO	Chief Executive Officer	68	2005-12-31

Director	Title	Age	Since
Eung-Soo Cho BRD	Director/Board Member	70	2015-11-30
Eung-Jun Cho CHM	Chairman	72	-
Sang-Il Kim BRD	Director/Board Member	51	2025-09-29

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ASTA CORPORATION	-2.57%	-.--%	+14.53%	-33.59%	64.49M
ABBOTT LABORATORIES	-0.04%	+2.25%	-34.47%	-16.25%	158B
MEDTRONIC PLC	-0.62%	+2.55%	-6.91%	-8.40%	103B
HOYA CORPORATION	+0.15%	-7.47%	+53.71%	+57.85%	54.49B
CENCORA, INC.	+1.20%	+2.66%	-3.28%	+51.58%	55.35B
BECTON, DICKINSON AND COMPANY	+2.68%	+4.35%	-13.87%	-42.40%	40.72B
MEDLINE INC.	+2.12%	-1.02%	-	-	30.48B
DEXCOM, INC.	+1.20%	-2.08%	-20.35%	-44.97%	26.91B
WEST PHARMACEUTICAL SERVICES, INC.	+1.20%	+5.20%	+52.87%	-7.25%	24.05B
TERUMO CORPORATION	+0.46%	-2.92%	-18.22%	-3.58%	19.91B
Average	+0.59%	-1.06%	+2.67%	-5.22%	51.22B
Weighted average by Cap.	+0.55%	+0.86%	-7.47%	-1.25%

	2021	2022
Net sales	2.56B 3,953B 2.26B 2.08B 1.95B 3.65B 242B 3.72B 25.02B 9.69B 119B 9.63B 9.42B 415B	3.35B 5,158B 2.95B 2.72B 2.54B 4.76B 315B 4.85B 32.65B 12.65B 156B 12.56B 12.29B 541B
Net income	-3.53B -5,446B -3.11B -2.87B -2.68B -5.03B -333B -5.12B -34.47B -13.35B -164B -13.26B -12.97B -571B	-2.8B -4,316B -2.46B -2.27B -2.13B -3.98B -264B -4.06B -27.32B -10.58B -130B -10.51B -10.28B -453B
Net Debt	-5.5B -8,481B -4.84B -4.47B -4.18B -7.83B -518B -7.97B -53.68B -20.79B -256B -20.65B -20.2B -890B	-2.73B -4,204B -2.4B -2.21B -2.07B -3.88B -257B -3.95B -26.61B -10.31B -127B -10.24B -10.01B -441B